Can better heart blood flow predict how far you can walk? new study investigates.

NCT ID NCT07150299

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at 20 people with hypertrophic obstructive cardiomyopathy who are already on optimal medical therapy. Researchers want to see if changes in heart blood flow over one year are linked to changes in how far they can walk in six minutes. Participants will have two heart MRI scans and walking tests as part of their routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mavacamten

What this could lead to

If successful, this could help doctors better understand how medication improves blood flow and exercise capacity in people with hypertrophic cardiomyopathy.

What could go wrong

This is a small, early observational study with only 20 participants, so results may not apply to everyone. It looks at correlations, not direct treatment effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertrophic cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Vienna

    RECRUITING

    Vienna, 2362, Austria

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••